You searched for Humanized antibody - Page 18 of 44

More News! 14 Dec 2017

New Biotech in Oxford Takes on Arthritis of the Spine

…for the trial, expected to start in the first half of 2018. Namilumab is a human antibody that targets granulocyte macrophage-colony stimulating factor (GM-CSF). The antibody was originally developed by…

December 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2022

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

…company announced it had received confirmation of CE registration for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per in vitro diagnostic directive (IVDD) regulations. CE registration…

December 6, 2022 - 3 minutesmins - By Liza Laws

glioblastoma oncolytic virus transgene 2

News and Trends 20 Sep 2022

Collaboration to develop new glioblastoma combination therapy nets €1.06M

…by Amsterdam UMC and will help CimCure to study passive immunization. Additionally, Covalab will develop full-length and antibody fragments, to be used for CAR-T cells. This novel approach to antibody…

September 20, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 6 Jun 2017

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

…Pharma has in-licensed a new clinical-stage antibody candidate from Novo Nordisk to reinforce its position in the crowded space. In exchange for its anti-C5aR antibody, IPH5401, Novo Nordisk gets a…

June 6, 2017 - 2 minutesmins - By Melanie De Almeida

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

…form of antibody, Keytruda blocks the cancer cells’ ability to hide from the immune system. In melanoma patients treated with the drug, tumors are more likely to shrink compared to…

July 24, 2018 - 6 minutesmins - By Editorial Team

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…Squibb to collaborate to develop cancer treatment Antibody therapy company SystImmune is collaborating with Bristol Myers Squibb (BMS) to develop and commercialize BL-B01D1, a bispecific antibody-drug conjugate (ADC). The candidate…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 6 Apr 2020

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

…we can prevent or reduce deterioration in Covid-19 patients for which there are currently few treatments available.” Izana’s antibody therapy is a human monoclonal antibody targeting GM-CSF and is in…

April 6, 2020 - 2 minutesmins - By David Kirk

Interview 11 Sep 2017

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

…example, a bispecific antibody, we can do this in-house. We’ve been able to create two completely new next-generation antibody technology platforms, DuoBody and HexaBody for bispecific and immune effector function…

September 11, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 1 Dec 2023

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

…to $2.2 billion in milestone payments in exchange for Bristol Myers Squibb’s access to its antibody oligonucleotide conjugates (AOC) platform technology. The platform combines the technology of monoclonal antibodies and…

December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 10 Sep 2018

10 Biotech Companies in Berlin You Should Know

…clinical trials for ovarian and squamous cell carcinoma. The company recently signed a licensing agreement with Daiichi Sankyo to combine this antibody with the Japanese pharma’s antibody-drug conjugate technology. Noxxon…

September 10, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Nov 2022

Positive results of cancer treatment to be presented at Boston conference

…in Boston. Alderaan Biotechnology is a preclinical biotech company that focuses on monoclonal antibody development. It will be making announcements about the most recent development of its new antibody candidate,…

November 3, 2022 - 2 minutesmins - By Liza Laws

News and Trends 20 Oct 2022

AbbVie acquires LifeArc portfolio company DJS Antibodies

AbbVie has acquired LifeArc’s portfolio company DJS Antibodies Limited, a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled…

October 20, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

New Biotech in Oxford Takes on Arthritis of the Spine

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

Collaboration to develop new glioblastoma combination therapy nets €1.06M

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

10 Biotech Companies in Berlin You Should Know

Positive results of cancer treatment to be presented at Boston conference

AbbVie acquires LifeArc portfolio company DJS Antibodies

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!